Filana Therapeutics
FLNA
66 hedge funds and large institutions have $35.6M invested in Filana Therapeutics in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 16 closing their positions.
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
3% more funds holding
Funds holding: 64 → 66 (+2)
20% less capital invested
Capital invested by funds: $44.7M → $35.6M (-$9.07M)
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.55M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$3.18M |
| 3 |
Goldman Sachs
New York
|
+$605K |
| 4 |
6CM
683 Capital Management
New York
|
+$575K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$435K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$8.22M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.95M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.85M |
| 4 |
State Street
Boston,
Massachusetts
|
-$707K |
| 5 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
-$672K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GC
76
Guggenheim Capital
Chicago,
Illinois
| – | -$31K | -2,299 | Closed |
|
|
NCCM
77
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$29K | -2,200 | Closed |
|
|
PCM
78
Prelude Capital Management
New York
| – | -$18K | -1,329 | Closed |
|
79
AllianceBernstein
Nashville,
Tennessee
| – | -$4K | -286 | Closed |
|
80
BNP Paribas Financial Markets
Paris,
France
| – | -$1.74K | -132 | Closed |
|
FLNA Hedge Fund Activity: Q2 2015 in Review
66 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2015, worth a combined $35.6M — down 20% from $44.7M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FLNA positions and 16 closed out — a net gain of 2 holders — while 17 added to existing stakes and 22 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $4.55M. The largest seller was Visium Asset Management, exiting entirely with an estimated $8.22M sold.
- 66 institutional investors held Filana Therapeutics (FLNA) as of Q2 2015, up from 64 in Q1 2015.
- Funds reported $35.6M of Filana Therapeutics stock for Q2 2015, down 20% quarter-over-quarter.
- 18 funds opened new Filana Therapeutics positions in Q2 2015 and 16 closed out, a net change of +2 holders.
- The largest Filana Therapeutics buyer in Q2 2015 was Nantahala Capital Management, an estimated $4.55M added.
- The largest Filana Therapeutics seller in Q2 2015 was Visium Asset Management, an estimated $8.22M sold.
Based on aggregated 13F filings for Q2 2015.